Financial Reports Latest Updates Industry Maps Economic Calendar

BIOLIFE SOLUTIONS INC (BLFS) Annual Reports

Q: Where can I read BIOLIFE SOLUTIONS INC (BLFS) annual reports?

Every year on this page links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser. 3 filings are currently indexed.

Q: What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer; a 20-F is filed by foreign private issuers (Taiwanese companies with US ADRs, such as TSMC, file 20-F). A 40-F applies to Canadian issuers under the MJDS.

BIOLIFE SOLUTIONS INC is listed on Nasdaq, classified by the SEC under Electromedical & Electrotherapeutic Apparatus (SIC 3845). This page indexes 3 annual reports, each linking to the full text on the SEC's EDGAR system.

Company profile

Exchange： Nasdaq
Fiscal year end： 12/31
SEC CIK： 834365 →

Website：Official site ↗

Financial Highlights

FY2026 Q2 (quarterly, ended 2026-06-30)
	Current	Prior year	YoY
Revenue	$28.5M	$25.4M	+12.0%
Operating income	$1.7M	$-16.6M	+110.2%
Net income	$45.1M	$-15.8M	+384.8%
EPS (diluted)	$0.91	$-0.33	+375.8%

Source: SEC EDGAR (XBRL company facts)

Financial history

Revenue & profit

Quarterly · In mn (USD)

Revenue 28.5 mn Net income 45.1 mn

Show table：Income statement

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	0.47	0.52	0.58	0.61	0.62	0.72	0.81	0.84	1.10	1.68	2.05	2.16	2.33	2.17	2.29	2.07	1.21	1.24	1.67	1.50	1.50	1.63	1.82	1.85	1.99	2.14	2.25	2.37	2.56	2.96	3.13	—	3.81	5.18	5.29	5.46	—	5.77	6.70	6.60	8.30	12.2	9.92	11.3	14.7	16.9	31.2	33.8	37.3	36.2	40.5	40.8	44.3	37.7	39.5	33.3	32.7	31.7	28.3	30.6	-3.42	23.9	25.4	28.1	18.8	27.5	28.5
Gross profit	0.19	0.22	0.21	0.24	0.33	0.37	0.46	0.49	0.46	0.6	0.75	1.13	0.83	0.89	0.92	0.9	0.55	0.59	1.00	0.88	0.82	0.97	1.14	1.08	1.12	1.21	1.37	1.44	1.60	1.87	1.84	—	2.45	3.64	3.69	3.75	—	4.12	4.74	4.52	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	41.3	—	—	—	50.1	14.8	15.2	—	32.1	17.5	18.3
Operating income	-0.39	-0.29	-0.32	-0.45	-0.26	-0.28	-0.21	-0.18	-0.31	-0.15	-0.31	0.19	-0.08	-0.11	-0.28	-0.37	-0.89	-0.87	-1.00	-1.16	-1.16	-1.30	-1.40	-1.49	-1.59	-1.14	-0.63	-0.46	-0.34	-0.03	-0.22	—	0.14	1.28	1.19	1.04	—	0.49	0.92	-0.6	-1.03	0.37	0.04	-1.25	-4.74	-0.98	-4.55	-11.2	-17.2	-7.63	-76.3	-11.4	-50.2	-13.6	-15.3	-28.8	-13.2	-10.1	-2.79	-1.56	1.39	-1.22	-16.6	-0.09	1.35	0.03	1.70
Net income	-0.54	-0.44	-0.47	-0.63	-0.44	-0.48	-0.41	-0.3	-0.5	-0.35	-0.51	-0.01	-0.28	-0.31	-0.48	-0.56	-0.88	-0.86	-0.91	-1.03	-0.99	-1.07	-1.12	-1.23	-1.36	-0.97	-3.32	-0.87	-0.77	-0.32	-0.56	4.87	0	1.14	1.23	0.89	-19.2	0.43	0.84	9.32	-12.2	22.3	-16.4	-1.13	-2.13	-1.12	7.88	0.08	-14.5	-7.07	-72.5	-9.96	-50.2	-13.7	-10.2	-29.1	-13.4	-10.2	-20.7	-1.70	12.5	-0.45	-15.8	0.62	11.1	1.19	45.1

Balance sheet

Quarterly · In mn (USD)

Total assets 447 mn Total liabilities 27.5 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Current assets	—	—	0.81	—	1.01	1.04	1.16	1.37	1.51	1.78	1.63	1.92	1.82	1.66	1.88	14.7	13.5	12.8	12.2	11.0	9.30	8.28	6.97	5.31	4.92	4.97	4.63	5.58	5.68	6.37	9.93	—	10.2	18.8	38.3	37.6	—	39.2	29.1	32.1	24.1	26.4	46.3	128	115	117	127	131	126	119	118	136	138	133	120	117	121	112	88.2	89.4	149	131	125	127	137	133	135
Total assets	—	—	1.31	—	1.47	1.56	1.66	1.87	3.07	3.42	3.17	3.42	3.44	3.21	3.35	16.0	14.8	14.3	16.1	15.2	13.9	13.2	12.4	10.8	10.6	10.8	7.93	8.60	8.48	8.88	12.1	—	12.3	21.8	46.5	45.5	—	48.1	51.7	84.2	92.8	95.0	114	196	235	240	521	559	554	544	470	488	450	446	433	411	413	402	375	382	399	395	387	392	406	401	447
Current liabilities	—	—	0.34	—	0.5	0.52	0.58	0.69	1.02	1.47	1.37	1.47	1.42	1.23	1.63	1.06	0.61	0.83	1.26	1.46	1.16	1.63	1.73	1.48	2.26	3.46	1.13	1.09	1.05	1.09	1.51	—	1.31	1.66	2.10	1.94	—	2.70	3.09	4.94	7.67	25.5	7.49	8.36	15.6	16.4	31.3	35.8	40.4	35.0	33.3	37.0	44.6	47.3	39.6	42.6	42.2	38.7	30.8	32.2	32.7	27.7	28.3	27.1	23.0	18.3	13.9
Total liabilities	—	—	10.9	—	12.0	12.4	12.8	13.3	14.8	15.4	15.7	15.8	16.1	16.1	16.6	1.90	1.41	1.59	2.14	2.31	1.99	2.44	2.51	2.25	3.00	4.18	4.76	5.80	1.66	1.67	2.05	—	1.82	2.13	2.52	2.32	—	3.71	5.48	7.27	49.4	27.3	8.13	9.04	29.6	31.3	68.7	70.1	73.9	65.5	58.1	79.4	86.0	88.4	81.0	79.1	75.0	68.2	53.5	56.2	50.6	42.5	40.1	38.3	34.0	28.7	27.5
Equity	—	—	-9.55	—	-10.5	-10.8	-11.2	-11.4	-11.7	-12.0	-12.5	-12.4	-12.7	-12.9	-13.3	14.1	13.4	12.7	11.8	10.8	10.0	9.15	9.86	7.44	6.82	6.16	3.17	2.80	6.82	7.21	10.1	—	10.5	19.7	43.9	43.1	—	44.4	46.3	77.0	43.5	67.7	106	187	205	209	452	489	480	479	412	408	364	358	352	332	338	333	321	325	349	353	347	354	372	372	420

Cash flow

Quarterly · In mn (USD)

Operating 6.35 mn Investing -1.58 mn Financing -3.59 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Operating	-0.66	-0.31	-0.28	-0.3	-0.24	-0.25	-0.19	-0.07	0.76	0	0.17	-0.13	0.21	-0.01	0.08	-0.89	-0.87	-0.7	-0.7	-1.31	-1.23	-1.17	-1.27	-1.59	-1.18	-0.88	-0.67	-0.17	-0.1	0.07	0.8	0.39	0.39	0.56	0.81	0.59	1.15	1.15	-0.07	1.14	-1.00	0.69	4.20	-0.5	2.26	1.82	-7.72	2.08	-0.77	-7.92	-9.92	1.50	7.86	-2.71	-7.72	-4.38	2.31	-4.47	6.46	4.80	1.65	1.73	7.37	6.10	4.92	-0.49	6.35
Investing	—	-0.02	-0.01	-0.01	-0.03	-0.01	-0.04	-0.05	-0.98	-0.15	0.02	-0.03	-0.19	-0.01	0	-0.02	-6.14	-1.93	-0.04	1.72	2.10	-0.4	0.82	1.07	-0.21	-0.19	-0.27	-0.04	-0.04	-0.01	-0.05	-0.04	-0.04	-1.02	-5.28	-0.16	-0.16	-0.16	-12.6	-0.29	-14.0	-1.23	-0.46	-0.97	-22.1	-4.43	-4.22	-2.01	-2.54	-2.27	-25.1	-15.9	-14.9	2.93	9.29	1.66	3.96	-0.22	-13.4	-1.68	73.6	-27.2	-39.5	-5.97	1.14	-1.83	-1.58
Financing	—	0.85	0.3	0.35	0.27	0.25	0.23	0.18	0.3	0	0	0.03	0	0.03	0	13.6	0.08	0	0	0.02	0.06	0.02	0.27	0.01	1.05	1.13	0.98	1.09	0.17	0.45	3.08	0.02	0.02	7.59	22.7	-2.15	0.18	0.18	0.41	0.74	0.27	0.49	19.7	80.6	1.27	1.22	-0.83	-1.06	-2.10	-0.18	-0.29	17.4	-0.62	-0.56	0.7	0.61	9.84	-0.95	-0.7	-1.04	-4.09	-2.99	-2.88	-2.56	-2.50	-7.89	-3.59
Cash at period end	0.07	0	0	0.04	0.04	0.02	0.02	0.07	0.16	0.01	0.2	0.06	0.08	0.08	0.16	12.8	5.90	3.28	2.54	2.97	3.90	2.35	2.17	1.66	1.32	1.37	1.41	2.29	2.31	2.83	6.66	7.03	7.03	14.2	32.4	30.7	31.8	31.8	19.6	21.2	6.45	6.40	29.9	94.0	90.4	89.0	76.3	75.1	69.9	59.5	24.0	27.0	19.4	19.1	21.4	19.2	35.4	29.7	22.0	24.0	95.4	66.9	31.9	29.5	33.0	22.8	24.0

Profitability

Quarterly · %

Gross margin 64.2% Operating margin 6.0% Net margin 158.4%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Gross margin	41.4%	42.8%	36.0%	39.6%	53.6%	51.7%	56.5%	58.6%	41.5%	35.4%	36.7%	52.1%	35.6%	41.0%	40.2%	43.8%	45.0%	47.3%	59.8%	58.8%	54.7%	59.6%	62.6%	58.4%	56.1%	56.9%	60.7%	60.8%	62.6%	63.0%	58.7%	—	64.3%	70.3%	69.7%	68.7%	—	71.5%	70.8%	68.4%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	126.2%	—	—	—	—	61.8%	59.9%	—	170.8%	63.6%	64.2%
Operating margin	-83.7%	-54.5%	-54.7%	-74.4%	-41.8%	-39.8%	-26.0%	-21.4%	-27.9%	-8.8%	-15.0%	8.9%	-3.6%	-5.1%	-12.4%	-17.9%	-73.3%	-70.3%	-60.1%	-77.3%	-77.2%	-79.4%	-77.2%	-80.6%	-80.1%	-53.3%	-27.9%	-19.6%	-13.3%	-1.1%	-7.0%	—	3.7%	24.8%	22.6%	19.1%	—	8.5%	13.7%	-9.0%	-12.4%	3.0%	0.4%	-11.1%	-32.2%	-5.8%	-14.6%	-33.0%	-46.2%	-21.1%	-188.2%	-28.0%	-113.5%	-36.1%	-38.7%	-86.4%	-40.2%	-31.9%	-9.9%	-5.1%	—	-5.1%	-65.5%	-0.3%	7.2%	0.1%	6.0%
Net margin	-114.8%	-83.2%	-81.7%	-103.2%	-70.1%	-66.9%	-50.8%	-35.5%	-45.5%	-20.9%	-25.0%	-0.3%	-12.1%	-14.3%	-21.2%	-27.1%	-72.9%	-69.4%	-54.6%	-68.7%	-66.4%	-65.5%	-61.5%	-66.2%	-68.2%	-45.4%	-147.7%	-36.8%	-30.0%	-10.8%	-17.8%	—	0.1%	22.0%	23.3%	16.4%	—	7.4%	12.5%	141.1%	-147.5%	183.4%	-165.1%	-10.1%	-14.4%	-6.6%	25.2%	0.2%	-38.8%	-19.5%	-179.0%	-24.4%	-113.5%	-36.4%	-25.8%	-87.4%	-40.9%	-32.2%	-73.1%	-5.6%	—	-1.9%	-62.3%	2.2%	58.9%	4.3%	158.4%

Returns & leverage

Quarterly · %

ROE 15.1% ROA 13.9% Debt ratio 6.1%

ROE / ROA = trailing four-quarter net income ÷ average equity / total assets (annual mode: the year’s net income ÷ average of opening and closing). Not computed when the denominator is zero or negative.

Show table：Returns & leverage

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
ROE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-195.2%	-608.2%	—	—	-29.6%	-32.5%	-36.7%	-38.9%	-48.2%	-56.6%	-61.0%	-105.6%	-127.2%	-86.9%	-79.0%	-37.9%	—	46.3%	40.6%	26.8%	7.6%	—	-51.9%	-37.7%	-14.3%	-3.8%	36.1%	4.0%	-5.6%	2.1%	-15.0%	1.3%	1.4%	-2.2%	-4.0%	-21.8%	-23.2%	-33.1%	-35.0%	-22.0%	-27.9%	-18.9%	-18.2%	-21.8%	-14.0%	-5.9%	-3.0%	-1.6%	-0.9%	-1.3%	-0.8%	15.1%
ROA	—	—	—	—	-134.1%	-128.9%	-131.7%	-86.8%	-74.2%	-62.6%	-68.7%	-51.8%	-35.5%	-33.5%	-33.2%	-16.9%	-24.5%	-31.9%	-33.1%	-23.7%	-26.5%	-29.2%	-29.6%	-34.0%	-39.1%	-38.9%	-67.8%	-67.3%	-62.3%	-53.8%	-25.1%	—	38.5%	35.6%	24.7%	7.2%	—	-47.5%	-34.6%	-13.2%	-1.8%	28.3%	3.6%	-5.3%	1.6%	-12.4%	1.1%	1.3%	-1.9%	-3.5%	-19.0%	-19.9%	-27.8%	-29.6%	-18.6%	-23.0%	-15.4%	-14.8%	-18.2%	-11.6%	-5.0%	-2.6%	-1.4%	-0.8%	-1.1%	-0.7%	13.9%
Debt ratio	—	—	829.5%	—	812.2%	791.8%	772.7%	711.5%	482.6%	452.1%	493.9%	462.7%	468.4%	501.0%	495.8%	11.9%	9.5%	11.1%	13.3%	15.3%	14.4%	18.5%	20.3%	20.8%	28.5%	38.8%	60.1%	67.4%	19.6%	18.8%	16.9%	—	14.8%	9.8%	5.4%	5.1%	—	7.7%	10.6%	8.6%	53.2%	28.7%	7.1%	4.6%	12.6%	13.0%	13.2%	12.5%	13.3%	12.0%	12.3%	16.3%	19.1%	19.8%	18.7%	19.3%	18.2%	17.0%	14.3%	14.7%	12.7%	10.8%	10.3%	9.8%	8.4%	7.2%	6.1%

EPS

Quarterly · US$

EPS US$0.91

Show table：EPS

Item	2010Q2	2010Q3	2010Q4	2011Q1	2011Q2	2011Q3	2011Q4	2012Q1	2012Q2	2012Q3	2012Q4	2013Q1	2013Q2	2013Q3	2013Q4	2014Q1	2014Q2	2014Q3	2014Q4	2015Q1	2015Q2	2015Q3	2015Q4	2016Q1	2016Q2	2016Q3	2016Q4	2017Q1	2017Q2	2017Q3	2017Q4	2018Q1	2018Q1	2018Q2	2018Q3	2018Q4	2019Q1	2019Q1	2019Q2	2019Q3	2019Q4	2020Q1	2020Q2	2020Q3	2020Q4	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
EPS（US$）	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.06	-0.03	-0.05	—	-0.01	0.05	0.05	0.04	—	0.02	0.03	0.37	-0.52	-0.01	-0.70	-0.04	-0.04	-0.03	0.19	0.00	-0.37	—	-1.71	-0.23	-1.18	-0.32	-0.23	-0.67	-0.30	-0.22	-0.45	-0.04	0.27	-0.01	-0.33	0.01	0.23	0.02	0.91

Revenue & profit

Year-to-date · In mn (USD)

Revenue 56.0 mn Net income 46.3 mn

Year-to-date = summed from the first quarter of the fiscal year; balance-sheet items are period-end balances.

Balance sheet

Year-to-date · In mn (USD)

Total assets 447 mn Total liabilities 27.5 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Cash flow

Year-to-date · In mn (USD)

Operating 5.86 mn Investing -3.41 mn Financing -11.5 mn

Positive = cash in, negative = cash out.

Profitability

Year-to-date · %

Gross margin 63.9% Operating margin 3.1% Net margin 82.7%

Gross, operating and net margin = the respective profit ÷ revenue.

Returns & leverage

Year-to-date · %

ROE 15.1% ROA 13.9% Debt ratio 6.1%

EPS

Year-to-date · US$

EPS US$0.93

Revenue & profit

Annual · In mn (USD)

Revenue 96.2 mn Net income -4.59 mn

Annual = sum of four quarters of a complete fiscal year (incomplete years are omitted); balance-sheet items are year-end balances.

Show table：Income statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2.76	5.66	8.95	6.19	6.45	8.23	11.0	—	—	48.1	119	162	143	87.2	96.2
Gross profit	1.40	2.29	3.76	3.04	3.81	4.78	6.75	—	—	—	—	—	—	—	—
Operating income	-1.21	-0.94	-0.29	-3.14	-5.02	-4.85	-1.06	—	—	-5.57	-33.9	-146	-70.8	-13.1	-16.6
Net income	-1.96	-1.66	-1.08	-3.22	-4.21	-6.88	-2.52	8.14	-20.8	2.67	-7.63	-140	-66.4	-20.2	-4.59

Balance sheet

Annual · In mn (USD)

Total assets 406 mn Total liabilities 34.0 mn

Equity = assets − liabilities. Balance-sheet figures are period-end balances, not cumulative.

Show table：Balance sheet

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Current assets	1.16	1.63	1.88	12.2	6.97	4.63	9.93	37.6	24.1	115	126	138	121	149	137
Total assets	1.66	3.17	3.35	16.1	12.4	7.93	12.1	45.5	92.8	235	554	450	413	399	406
Current liabilities	0.58	1.37	1.63	1.26	1.73	1.13	1.51	1.94	7.67	15.6	40.4	44.6	42.2	32.7	23.0
Total liabilities	12.8	15.7	16.6	2.14	2.51	4.76	2.05	2.32	49.4	29.6	73.9	86.0	75.0	50.6	34.0
Equity	-11.2	-12.5	-13.3	11.8	9.86	3.17	10.1	43.1	43.5	205	480	364	338	349	372

Cash flow

Annual · In mn (USD)

Operating 20.1 mn Investing -71.5 mn Financing -10.9 mn

Positive = cash in, negative = cash out.

Show table：Cash flow statement

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Operating	-0.99	0.85	0.15	-3.16	-4.97	-4.33	0.61	2.74	2.36	6.65	-4.59	-8.49	-12.5	8.43	20.1
Investing	-0.09	-1.15	-0.24	-8.14	4.24	0.39	-0.14	-6.54	-27.2	-24.7	-13.2	-58.1	17.8	58.3	-71.5
Financing	1.10	0.48	0.05	13.7	0.37	3.17	4.80	28.2	1.77	102	-2.78	16.3	10.6	-6.78	-10.9
Cash at period end	0.02	0.2	0.16	2.54	2.17	1.41	6.66	30.7	6.45	90.4	69.9	19.4	35.4	95.4	33.0

Profitability

Annual · %

Gross margin 61.2% Operating margin -17.3% Net margin -4.8%

Gross, operating and net margin = the respective profit ÷ revenue.

Show table：Profitability

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Gross margin	50.9%	40.5%	42.0%	49.0%	59.1%	58.1%	61.2%	—	—	—	—	—	—	—	—
Operating margin	-43.9%	-16.6%	-3.2%	-50.6%	-77.8%	-59.0%	-9.6%	—	—	-11.6%	-28.5%	-90.0%	-49.4%	-15.0%	-17.3%
Net margin	-70.9%	-29.3%	-12.1%	-52.0%	-65.3%	-83.6%	-22.8%	—	—	5.5%	-6.4%	-86.4%	-46.4%	-23.1%	-4.8%

Returns & leverage

Annual · %

ROE -1.3% ROA -1.1% Debt ratio 8.4%

Show table：Returns & leverage

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE	—	—	—	—	-38.9%	-105.6%	-37.9%	30.6%	-48.1%	2.1%	-2.2%	-33.1%	-18.9%	-5.9%	-1.3%
ROA	-117.7%	-68.7%	-33.2%	-33.1%	-29.6%	-67.8%	-25.1%	28.3%	-30.1%	1.6%	-1.9%	-27.8%	-15.4%	-5.0%	-1.1%
Debt ratio	772.7%	493.9%	495.8%	13.3%	20.3%	60.1%	16.9%	5.1%	53.2%	12.6%	13.3%	19.1%	18.2%	12.7%	8.4%

EPS

Annual · US$

EPS US$-0.10

Show table：EPS

Item	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
EPS（US$）	—	—	—	—	—	—	—	—	—	-0.79	-0.21	—	-1.52	-0.44	-0.10

Source: SEC EDGAR (XBRL company facts)

Annual reports by year

	10-K
2025	Open full text →
2024	Open full text →
2023	Open full text →

10-K: annual report of a US domestic issuer. Filings are the original documents hosted on SEC EDGAR — this site neither mirrors nor edits them.

FAQ

Where can I read BIOLIFE SOLUTIONS INC (BLFS) annual reports?

Every year in the table above links straight to the full text on SEC EDGAR. US annual reports are web pages (HTML) rather than PDFs, so you can read and search them in the browser without downloading anything. 3 filings are currently indexed.

What is the difference between a 10-K and a 20-F?

A 10-K is the annual report of a US domestic issuer, with sections fixed by law: Item 1 Business, Item 1A Risk Factors, Item 7 Management's Discussion and Analysis. A 20-F is filed by foreign private issuers — Taiwanese companies with US ADRs, such as TSMC, file 20-F rather than 10-K. A 40-F applies to Canadian issuers under the MJDS.

Are earnings call materials available here?

No. Earnings calls are not SEC filings, so US pages on this site cover annual reports only. Taiwan has a mandatory investor-conference disclosure regime, and those materials are indexed under Annual Reports.

Source: US Securities and Exchange Commission (SEC) EDGAR. This site indexes public filings and links to them; it hosts no copies, offers no investment advice, and makes no warranty as to timeliness or completeness.
Back to US annual reports, or see the supply-chain maps.